Veronika Wirtz, PhD, MSc

Associate Professor, Global Health


Veronika J. Wirtz, MSc, PhD has pursued a full-time career in international public health over the last ten years. She has been involved in a wide range of studies and program evaluations focusing on medicines access and utilization. Her current interest and expertise include medicines price analysis, generic medicines policies, access to medicines for non-communicable diseases and the role of the private sector to promote equitable access and efficient use of medicines in low and middle income countries. Among other international studies Dr Wirtz carried out cross-national comparison of medicines consumption using large sales data bases to inform policy making about adequate use of medicines and prevention of antimicrobial resistance. From 2004 to 2012 she was researcher and lecturer at the National Institute of Public Health in Mexico and a founding member and Head of the Medicines in Public Health Research Group which is a multi-disciplinary team of 15 experts in health economics, epidemiology, social science carrying out pharmaceutical policy analysis in Mexico and Latin America. She has worked as a technical advisor for various international organizations, among them the World Health Organization, the Pan American Health Organization, the Global Fund to fight AIDS, Tuberculosis and Malaria, the Bill and Melinda Gates Foundation, Health Action International and the Ford Foundation. She has also worked with the Ministry of Health in Mexico on various program evaluations and capacity building initiatives. She published widely in international peer review journals such as The Lancet, British Medical Journal, World Health Organization Bulletin, Health Policy and Planning, Health Policy, Value in Health, Social Science and Medicine, Tropical Medicine and International Health. She received her training as a pharmacist from Albert-Ludwigs-University in Freiburg, Germany and her Master in Clinical Pharmacy and PhD from the University of London in the UK.


  • University of London, PhD
  • University of London, MSc

Classes Taught

  • SPHIH704
  • SPHIH880
  • SPHIH943
  • SPHPH740


  • Published on 5/22/2014

    Pérez-Cuevas R, Doubova SV, Wirtz VJ, Servan-Mori E, Dreser A, Hernández-Ávila M. Effects of the expansion of doctors'' offices adjacent to private pharmacies in Mexico: secondary data analysis of a national survey. BMJ Open. 2014; 4(5):e004669.

    Read at: PubMed
  • Published on 10/16/2013

    Santa-Ana-Tellez Y, Mantel-Teeuwisse AK, Dreser A, Leufkens HG, Wirtz VJ. Impact of Over-the-Counter Restrictions on Antibiotic Consumption in Brazil and Mexico. PLoS One. 2013; 8(10):e75550.

    Read at: PubMed
  • Published on 10/5/2013

    Van Bever E, Wirtz VJ, Azermai M, De Loof G, Christiaens T, Nicolas L, Van Bortel L, Vander Stichele R. Operational rules for the implementation of INN prescribing. Int J Med Inform. 2014 Jan; 83(1):47-56.

    Read at: PubMed
  • Published on 9/30/2013

    Kaplan WA, Wirtz VJ, Stephens P. The market dynamics of generic medicines in the private sector of 19 low and middle income countries between 2001 and 2011: a descriptive time series analysis. PLoS One. 2013; 8(9):e74399.

    Read at: PubMed
  • Published on 7/20/2013

    Wirtz VJ, Vian T, Kaplan WA, Simon JL. Measuring universities' commitments to global health. Lancet. 2013 Jul 20; 382(9888):204-5.

    Read at: PubMed
  • Published on 7/5/2013

    Galárraga O, Wirtz VJ, Santa-Ana-Tellez Y, Korenromp EL. Financing HIV programming: how much should low- and middle-income countries and their donors pay? PLoS One. 2013; 8(7):e67565.

    Read at: PubMed
  • Published on 5/1/2013

    Wirtz VJ, Dreser A, Heredia-Pi I. [Challenges and opportunities for the development of a national pharmaceutical policy in México]. Salud Publica Mex. 2013 May-Jun; 55(3):329-36.

    Read at: PubMed
  • Published on 3/29/2013

    Wirtz VJ, Herrera-Patino JJ, Santa-Ana-Tellez Y, Dreser A, Elseviers M, Vander Stichele RH. Analysing policy interventions to prohibit over-the-counter antibiotic sales in four Latin American countries. Trop Med Int Health. 2013 Jun; 18(6):665-73.

    Read at: PubMed
  • Published on 2/12/2013

    Hogerzeil HV, Liberman J, Wirtz VJ, Kishore SP, Selvaraj S, Kiddell-Monroe R, Mwangi-Powell FN, von Schoen-Angerer T. Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration. Lancet. 2013 Feb 23; 381(9867):680-9.

    Read at: PubMed
  • Published on 2/5/2013

    Wirtz VJ, Mol PG, Verdijk J, Vander Stichele RH, Taxis K. Use of antibacterial fixed-dose combinations in the private sector in eight Latin American Countries between 1999 and 2009. Trop Med Int Health. 2013 Apr; 18(4):416-25.

    Read at: PubMed

View 42 more publications: